Efficacy of Preoperative Intra Gastric Balloon in Morbidly Obese Patients Selected for Gastric By-pass (BIGPOM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00504036|
Recruitment Status : Completed
First Posted : July 19, 2007
Last Update Posted : November 1, 2011
|Condition or disease||Intervention/treatment||Phase|
|Morbid Obesity||Device: inflatable intra-gastric balloon||Not Applicable|
On inclusion, comorbidities associated with obesity will be recorded. After recording of the informed consent patients will be randomized in two groups: usual care or intra-gastric balloon. In the latter, a second randomization will be performed between air-filled balloon or water-filled balloon. Six months later, after withdrawal of the balloon (if required), laparoscopic gastric by-pass will be performed. Thereafter, patients will be followed during 6 months.
On each visit, inclusion, 3 months, 6 months, surgery, 1 month and 6 months post surgery, a medical and biological evaluation will be systematically performed.
The main criteria of judgement is the rate of admission in ICU during more than 24 hrs during the 30 days following surgery.
The secondary criteria of judgement is: the differences in pre-operative weight loss between the 2 groups, number of complications occurring during the 30 days after surgery, differences in different scales of quality of life (SF36, IWQOL-lite), differences in operative time, length of hospital stay, readmissions, and medical cots between the two strategies. Efficacy and tolerance of each type of balloon (air-filled or water-filled) will be compared in the intra-gastric balloon group.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||314 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Medico Economic Evaluation of a Temporary (6 Months) Intra-gastric Balloon in Morbidly Obese Patients Before a Gastric By-pass. A Randomised Multicenter Study Comparing the Usual Strategy to Two Types of Gastric Balloon|
|Study Start Date :||October 2007|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|
Experimental: Intra-gastric balloon
Patients will receive either an air-filled or water-filled intra-gastric balloon.
Device: inflatable intra-gastric balloon
inflatable intra-gastric balloon
No Intervention: Usual care
Usual care will be given to the patients.
- Rate of admission in Intensive Care Units [ Time Frame: > 24 hrs during the 30-day period following gastric by-pass ]
- Differences in absolute weight loss [ Time Frame: at 6 months, before gastric by-pass, between the 2 strategies ]
- Number and types of complications occurring [ Time Frame: during the 30-day post-operative period ]
- Number of comorbidities present [ Time Frame: after the 6-month initial period ]
- Differences in quality of life [ Time Frame: at the end of first 6-month period and at the end of the study ]
- Differences in time of surgery, length of stay, readmission [ Time Frame: during the 30-day post by-pass period ]
- Differences in medical costs between the 2 strategies [ Time Frame: 6 months before and after gastric by-pass ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00504036
|Hopital Louis Mourier|
|Colombes, France, 92700|
|Principal Investigator:||Benoit Coffin, PU-PH||Assistance Publique - Hôpitaux de Paris|